NCT03784300View on ClinicalTrials.gov

A Safety Study of PTI-125 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

August 18, 2017

Primary Completion Date

October 9, 2017

Study Completion Date

March 27, 2018

Conditions

Alzheimer Disease, Early OnsetAlzheimer Disease

Interventions

DRUG

50 mg PTI-125

PTI-125 50 mg Oral Solution

DRUG

100 mg PTI-125

PTI-125 100 mg Oral Solution

DRUG

200 mg PTI-125

PTI-125 200 mg Oral Solution

Trial Locations (1)

78217

Worldwide Clinical Trials, San Antonio

Sponsors

Lead Sponsor

Pain Therapeutics

All Listed Sponsors

collaborator

National Institute on Aging (NIA)

NIH

lead

Pain Therapeutics

INDUSTRY

NCT03784300 - A Safety Study of PTI-125 in Healthy Volunteers | Biotech Hunter | Biotech Hunter